jiangsu xidi pharmaceuticals co.ltd.
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for jiangsu xidi pharmaceuticals co.ltd. from 2024 to 2025. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2025, the company has completed 1 transactions, with a transaction quantity of 0.5 and a transaction weight of 0.
- Year Transactions Quantity Weight
Bill of lading data
< 1/9 >- Trade date 2025/08/05 B/L No. 107414170511
- Supplier jiangsu xidi pharmaceuticals co.ltd. Buyers công ty cổ phần dược phẩm đạt vi phú
- POLs —— PODs ——
- Supply area China Purchas area Vietnam
- Weight —— Amount 66500
- Hs code 29339990 Product tags perindopril estrogen,sodium diacetyl benzoate
- Product description Nguyên liệu dược: Afatinib (Afatinib (Dimaleate)-In House,Batch no:DA344-241202, MFG date:17/12/2024, Retest date:16/12/2027, nsx: JIANGSU XIDI PHARMACEUTICAL CO., LTD. GPLH: 893110296225. Mới 100%. Expand
- Trade date 2025/01/07 B/L No. 106859328001
- Supplier jiangsu xidi pharmaceuticals co.ltd. Buyers công ty cổ phần dược phẩm đạt vi phú
- POLs —— PODs ——
- Supply area India Purchas area Vietnam
- Weight —— Amount 5150
- Hs code 29334990 Product tags isoquinoline,quinoline
- Product description Nguyên liệu dược dùng nghiên cứu: Lenvatinib Mesylate - Inhouse, batch: DA336(2)M-241001, mfg date: 28/10/2024, Exp date: 27/10/2026, nsx: JIANGSU XIDI PHARMACEUTICALS CO., LTD - China Expand
- Trade date 2023/08/01 B/L No. ——
- Supplier jiangsu xidi pharmaceuticals co.ltd. Buyers viet y trading exp imp joint stock co
- POLs —— PODs ——
- Supply area China Purchas area Vietnam
- Weight ——kg Amount 29160
- Hs code 29334990 Product tags isoquinoline,quinoline
- Product description PHARMACEUTICAL INGREDIENTS FOR RESEARCH DRUG: LENVATINIB CONTAINS 1 UNHYDROTED QINOLIN REGION, BATCH NO: DA336(2)M-221004; MANUFACTURER: OCTOBER 24, 2022, HSD: OCTOBER 23, 2024, 100% NEW Expand
- Trade date 2023/08/01 B/L No. ——
- Supplier jiangsu xidi pharmaceuticals co.ltd. Buyers viet y trading exp imp joint stock co
- POLs —— PODs ——
- Supply area China Purchas area Vietnam
- Weight ——kg Amount 29160
- Hs code 29334990 Product tags isoquinoline,quinoline
- Product description PHARMACEUTICAL INGREDIENTS FOR RESEARCH DRUG: LENVATINIB CONTAINS 1 UNHYDROTED QINOLIN REGION, BATCH NO: DA336(2)M-221004; MANUFACTURER: OCTOBER 24, 2022, HSD: OCTOBER 23, 2024, 100% NEW Expand
- Trade date 2022/11/30 B/L No. ——
- Supplier jiangsu xidi pharmaceuticals co.ltd. Buyers dat vi phu pharmaceutical joint sto
- POLs —— PODs ——
- Supply area China Purchas area Vietnam
- Weight —— Amount 4025
- Hs code 29419000 Product tags ceftriaxone sodium,entercavir,neomycin sulphate
- Product description NGUYÊN LIỆU DƯỢC DÙNG NGHIÊN CỨU: LENVATINIB MESYLATE - IN HOUSE, BATCH NO: DA336(2) M-221001-1, MFG DATE: 18/10/22, RETEST DATE: 17/10/24, NSX: JIANGSU XIDI PHARMACEUTICAL CO., LTD - CHINA @ Expand
- Trade date 2021/08/26 B/L No. ——
- Supplier jiangsu xidi pharmaceuticals co.ltd. Buyers dat vi phu pharmaceutical joint sto
- POLs hangzhou cn PODs ho chi minh airport vn
- Supply area China Purchas area Vietnam
- Weight —— Amount 3450
- Hs code 29419000 Product tags ceftriaxone sodium,entercavir,neomycin sulphate
- Product description NGUYÊN LIỆU DƯỢC:LENVATINIIB MESYLATE - IN HOUSE, BATCH NO: DA336(2)M-201201-2, MFG DATE: 12/2020, RETEST DATE:11/2022, MỚI 100%, NSX: JIANGSU XIDI PHARMACEUTICAL CO., LTD-CHINA (DÙNG ĐỂ THỬ NGHIỆM) @ Expand
- Trade date 2021/07/07 B/L No. ——
- Supplier jiangsu xidi pharmaceuticals co.ltd. Buyers dat vi phu pharmaceutical joint sto
- POLs hangzhou cn PODs ho chi minh airport vn
- Supply area China Purchas area Vietnam
- Weight —— Amount 13000
- Hs code 29339990 Product tags perindopril estrogen,sodium diacetyl benzoate
- Product description NGUYÊN LIỆU DƯỢC:AFATINIB (AFATINIB (DIMALEATE)-IN HOUSE,BATCH NO:DA344-210301, MFG DATE:05/03/21, RETEST DATE:04/03/23,MỚI 100%, NSX: JIANGSU XIDI PHARMACEUTICAL CO., LTD-CHINA (DÙNG ĐỂ THỬ NGHIỆM) @ Expand
- Trade date 2021/03/03 B/L No. ——
- Supplier jiangsu xidi pharmaceuticals co.ltd. Buyers dat vi phu pharmaceutical joint sto
- POLs shanghai cn PODs ho chi minh airport vn
- Supply area China Purchas area Vietnam
- Weight —— Amount 5
- Hs code 29419000 Product tags ceftriaxone sodium,entercavir,neomycin sulphate
- Product description NGUYÊN LIỆU DƯỢC: LENVATINIB MESYLATE (50G/TÚI) @ Expand
- Trade date 2021/03/03 B/L No. ——
- Supplier jiangsu xidi pharmaceuticals co.ltd. Buyers dat vi phu pharmaceutical joint sto
- POLs shanghai cn PODs ho chi minh airport vn
- Supply area China Purchas area Vietnam
- Weight —— Amount 5
- Hs code 29419000 Product tags ceftriaxone sodium,entercavir,neomycin sulphate
- Product description NGUYÊN LIỆU DƯỢC: LENVATINIB MESYLATE (20G/TÚI) @ Expand
Partners
Total 3- Rank Company Transactions Per Detail
- 1 dat vi phu pharmaceutical joint sto vietnambuyer,they trade on 2022-11-30 5 55.56% >
- 2 công ty cổ phần dược phẩm đạt vi phú vietnambuyer,they trade on 2025-08-05 2 22.22% >
- 3 viet y trading exp imp joint stock co vietnambuyer,they trade on 2023-08-01 2 22.22% >
Products
Total 2- Products Transactions Per Detail
-
isoquinoline
3 100% > -
quinoline
3 100% >
Hscode rank
Total 3- HSCode Name Transactions Per Detail
- HS 29334990 3 100% >
Trading Area
Total 1- Area Transactions Per Detail
- vietnam 9 100% >
Port statistics
Total 2- Port Name Transactions Per Detail
- hangzhou cn 2 22.22% >
- shanghai cn 2 22.22% >
jiangsu xidi pharmaceuticals co.ltd. is china Supplier,
and primarily engages in the import and export business of products such as isoquinoline，quinoline.
According to the 52wmb.com global trade database, as of 2025-08-05, the company has completed 9 international trades,
with its main trading regions covering vietnam etc.
The core products include HS29334990 etc,
often transported via hangzhou cn，port shanghai cn etc,
and its main trading partners are dat vi phu pharmaceutical joint sto，công ty cổ phần dược phẩm đạt vi phú，viet y trading exp imp joint stock co.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on jiangsu xidi pharmaceuticals co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool